Dr. Jan-Uwe Claas Email & Phone Number
Who is Dr. Jan-Uwe Claas? Overview
A concise factual answer block for searchers comparing this professional profile.
Dr. Jan-Uwe Claas is listed as Chief Executive Officer at PROVIREX Genome Editing Therapies GmbH, a with 11 employees, based in Oestrich-Winkel, Hesse, Germany. AeroLeads shows a matched LinkedIn profile for Dr. Jan-Uwe Claas.
Dr. Jan-Uwe Claas previously worked as Founder at Dr. Claas Consulting Gmbh and Expert Coach Healthcare & Mentor Entrepreneurship Program GeneNovate at Xplore By Unternehmertum. Dr. Jan-Uwe Claas holds Certification, International Directors Program from Insead.
Email format at PROVIREX Genome Editing Therapies GmbH
This section adds company-level context without repeating Dr. Jan-Uwe Claas's masked contact details.
Review company-level records connected to Dr. Jan-Uwe Claas before choosing the right outreach path.
About Dr. Jan-Uwe Claas
I have more than 25 years of experience in Biotech, Medtech & Pharma industry covering a broad spectrum from Pre-clinical Research to Head International Marketing (SVP) & General Management. My key strengths are the highly successful launch of innovative brands on a national & international level to drive company growth & profitability as well as the leadership of complex organizations with proven success.My vast international experience is based on a more than 5-years GM position in UK, more than 4-years regional GM-EU role and a 6-years collaboration with an US based global player (Johnson & Johnson).I founded Dr. Claas Consulting in 02/22. Dr. Claas Consulting offers consultancy support for start-up and established business that intends to launch brands in Germany & Europe. My support can be project-based with a focus on strategy and operative implementation or as Interim-Manager (CEO, CCO, GM, Head Marketing). More information under: claas-consulting.com
Dr. Jan-Uwe Claas's current company
Company context helps verify the profile and gives searchers a useful next step.
Dr. Jan-Uwe Claas work experience
A career timeline built from the work history available for this profile.
Founder
CurrentDr. Claas Consulting supports Start-Up enterprises intending to set up new commercial business in European countries as well as companies with already established business, that intends to launch or re-launch brands in Europe. The support can be…- Project-based with a focus on strategy and/or operative implementation- Interim-Management based (CEO, CCO, GM)The specific benefits of Dr. Claas Consulting are the…- Broad range from strategy to implementation- Focus on optimized & targeted investment- Implementation oriented approach based on in-depth practical experience- 360-degree view across all functions
Expert Coach Healthcare & Mentor Entrepreneurship Program Genenovate
CurrentUnternehmerTUM’s pre-Incubation Program XPLORE supports founders with tech-based start-up project to prepare you for incubation and the acquisition of pre-seed capitalGeneNovate: Empowering Innovators and Entrepreneurs in Gene and Cell Therapies
Special Advisor To The Board Of Directors
CurrentKora Healthcare is a fully integrated healthcare company with core competencies across Research, Development & Innovation, Scientific & Medical Affairs, Regulatory Affairs & Pharmacovigilance, Quality, Supply Chain, Marketing & Sales, Finance and Customer Services.
Senior Consultant & Lead Facilitator
CurrentAs a senior consultant and lead facilitator, I lead a variety of learning programs like Healthcare Economics, Market Access, Healthcare Compliance, GxP & Drug Development that help advance capabilities from early on in career through executive leadership with a focus on the Health Care Industry. Based on my 30 years of experience in Health Care & Pharma I support professionals especially in the US Biotech industry to further develop their capabilities and skill-sets.
Business Angel
CurrentStartup in stealth mode (Biotechnology)
Partner
CurrentEach partner in the network has outstanding skills and has qualified in an intensive selection process to become a member. Practical experience is our strength. The partners of Healthcare Shapers are consultants with many years of practical experience in the healthcare industry. Our diversity promotes unconventional ideas, creating new insights and approaches.
Interim Head Of Marketing
Support the private equity funded international pharmaceutical company NEURAXPHARM in the transformation from generic business to provider of innovative brands.Successful launch of the new Anti-CD20 Antibody BRIUMVI for Multiple Sclerosis in the highly competitive German MS market.
General Manager Country Cluster Europe
General Manager responsible for the Country Cluster Europe Organization consisting of Portugal, Switzerland, Austria, Belgium, Luxembourg, Netherlands, Ireland, Sweden, Denmark, Norway and Finland. Full P&L responsibility. Key achievements after setting up the new organisational structure with 250 employees:Doubling the profit margin within 3 years, from 25 % in 2017 to 50 % in 2020. Key focus: Implement measures to improve team culture & quality of leadership and establish new governance structure & processes to foster cross-functional working.
Head Marketing Europe (Senior Vice President)
General Manager United Kingdom & Ireland
180 employees, full P&L responsibilityIncrease of UK Profit Margin from -23 % in 2011 to +38% in 2016 due to sales growth of innovations, focussed investment and improved quality of services. Establish Grϋnenthal UK as the key player in the pain market by introducing innovative customer services. Key focus: Close cooperation & alignment of all departments/teams, up-skilling of customer facing teams & improvement of market access.Appointed member of the ABPI (Association of the British Pharmaceutical Industry) Board of Directors. Grünenthal Best Performance Award 2013 for UK turnaround.
Senior Vice President Marketing Europe & Australia
Responsible for all innovative Grϋnenthal brands incl. brand communication, E-marketing and scientific marketing. Launch of Grϋnenthal's priority innovation (Palexia) across Europe and implementation of non-branded educational initiative in all EU countries (2015 EU sales >150 Mio €/ strong growth), Team size: 21 employees
Vice President Global Marketing
Global launch of new innovation (Palexia) from Grϋnenthal laboratories in cooperation with J&J. Responsible for Brand Communication, Scientific Marketing, Life Cycle Management and launch of global educational initiative together with international scientific societies and experts (CHANGE PAIN).
Head Of Global Marketing Narcotic Analgesics
Global marketing responsibility for all strong analgesics. Pre-launch preparation for global launch of new innovation (Palexia) from Grϋnenthal laboratories (1st new centrally acting analgesic in 25 years) in cooperation with J&J
Global Commercial Lead New Analgesics
Responsible for global commercial development of all new molecules invented by Grϋnenthal: Commercial responsibility in international partnering processesCommercial lead in global cooperation with J&J from clinical phase 2b into post launchCommercial lead in 2 year project to assess US market presence via payer, prescriber & patient research
Head Of Marketing Germany
Responsible for marketing team (5-8 reports) and marketing budget (9 Mio €)Launch of new analgesic, monthly sales of 3,7 Mio € in 08/2004Introduction of new educational workshop program: 10.000 physicians p.a.
Productmanager Risperdal
Responsible for all marketing activities and marketing budget (> 10 Mio DM)2001 Risperdal sales above 100 Mio DM
Head Of Medical Marketing Oncology
Responsible for Key opinion leader management and Investigator Initiated Studies in GermanyDevelopment of scientifc communication strategy later implemented across Europe
Medical Manager Oncology
Scientific Productmanager Infectiology
Dr. Jan-Uwe Claas education
Certification, International Directors Program
Organizational Consultant - Organisationsentwickler
Dr. Rer. Nat. (Phd), Microbiology, Biochemistry, Organic Chemistry, Magna Cum Laude
Diplom, Microbiology, Biochemistry, Organic Chemistry, Sehr Gut (A Level Equivalent)
Frequently asked questions about Dr. Jan-Uwe Claas
Quick answers generated from the profile data available on this page.
What company does Dr. Jan-Uwe Claas work for?
Dr. Jan-Uwe Claas works for PROVIREX Genome Editing Therapies GmbH.
What is Dr. Jan-Uwe Claas's role at PROVIREX Genome Editing Therapies GmbH?
Dr. Jan-Uwe Claas is listed as Chief Executive Officer at PROVIREX Genome Editing Therapies GmbH.
Where is Dr. Jan-Uwe Claas based?
Dr. Jan-Uwe Claas is based in Oestrich-Winkel, Hesse, Germany while working with PROVIREX Genome Editing Therapies GmbH.
What companies has Dr. Jan-Uwe Claas worked for?
Dr. Jan-Uwe Claas has worked for Provirex Genome Editing Therapies Gmbh, Dr. Claas Consulting Gmbh, Xplore By Unternehmertum, Kora Healthcare, and Hands On L&D.
How can I contact Dr. Jan-Uwe Claas?
You can use AeroLeads to view verified contact signals for Dr. Jan-Uwe Claas at PROVIREX Genome Editing Therapies GmbH, including work email, phone, and LinkedIn data when available.
What schools did Dr. Jan-Uwe Claas attend?
Dr. Jan-Uwe Claas holds Certification, International Directors Program from Insead.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial